VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LMND
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LMNDLemonade, Inc.
$77.59$6.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLMNDQuarterly Financials

Lemonade, Inc. (LMND) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Lemonade, Inc. (LMND) quarterly income statement — complete revenue, gross profit & net income history

LMND Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue234.4M228.1M194.5M164.1M151.2M148.8M136.6M122M119.1M115.5M114.5M104.6M95.2M88.4M74M50M44.3M41M35.7M28.2M
Revenue Growth %55.03%53.29%42.39%34.51%26.95%28.83%19.3%16.63%25.11%30.66%54.73%109.2%114.9%115.61%107.28%77.31%88.51%98.07%100.56%-5.69%
Medical Costs & Claims133.3M84.5M113.7M98.9M111.5M53.1M97.7M89.3M83.2M58.7M91M90.9M77.2M57.6M65.4M37.8M33.5M23.2M23.8M18.2M
Medical Cost Ratio %56.87%37.05%58.46%60.27%73.74%35.69%71.52%73.2%69.86%50.82%79.48%86.9%81.09%65.16%88.38%75.6%75.62%56.59%66.67%64.54%
Gross Profit101.1M143.6M80.8M65.2M39.7M95.7M38.9M32.7M35.9M56.8M23.5M13.7M18M30.8M8.6M12.2M10.8M17.8M11.9M10M
Gross Margin %43.13%62.95%41.54%39.73%26.26%64.31%28.48%26.8%30.14%49.18%20.52%13.1%18.91%34.84%11.62%24.4%24.38%43.41%33.33%35.46%
Gross Profit Growth %154.66%50.05%107.71%99.39%10.59%68.49%65.53%138.69%99.44%84.42%173.26%12.3%66.67%73.03%-27.73%22%390.91%128.21%56.58%85.19%
Operating Expenses135.7M164.2M117.1M107.8M101.1M133.5M104.7M87.8M81.1M96.4M83.1M79.6M82.7M98.9M97.7M77.2M83.4M86.2M76.1M62.9M
OpEx / Revenue %57.89%71.99%60.21%65.69%66.87%89.72%76.65%71.97%68.09%83.46%72.58%76.1%86.87%111.88%132.03%154.4%188.26%210.24%213.17%223.05%
Depreciation & Amortization2.7M2.6M3.4M4.7M4.5M4.7M5.1M5.2M5M4.8M5M5.1M5.1M5.4M3.7M1.6M1.5M1.2M800K800K
Combined Ratio %114.76%109.03%118.66%125.96%140.61%125.4%148.17%145.16%137.95%134.29%152.05%163%167.96%177.04%220.41%230%263.88%266.83%279.83%287.59%
Operating Income-34.6M-20.6M-36.3M-42.6M-61.4M-37.8M-65.8M-55.1M-45.2M-39.6M-59.6M-65.9M-64.7M-68.1M-89.1M-65M-72.6M-68.4M-64.2M-52.9M
Operating Margin %-14.76%-9.03%-18.66%-25.96%-40.61%-25.4%-48.17%-45.16%-37.95%-34.29%-52.05%-63%-67.96%-77.04%-120.41%-130%-163.88%-166.83%-179.83%-187.59%
Operating Income Growth %43.65%45.5%44.83%22.69%-35.84%4.55%-10.4%16.39%30.14%41.85%33.11%-1.38%10.88%0.44%-38.78%-22.87%-50.94%-106.02%-110.49%-155.56%
EBITDA-31.9M-18M-32.9M-37.9M-56.9M-33.1M-60.7M-49.9M-40.2M-34.8M-54.6M-60.8M-59.6M-62.7M-85.4M-63.4M-71.1M-67.2M-63.4M-52.1M
EBITDA Margin %-13.61%-7.89%-16.92%-23.1%-37.63%-22.24%-44.44%-40.9%-33.75%-30.13%-47.69%-58.13%-62.61%-70.93%-115.41%-126.8%-160.5%-163.9%-177.59%-184.75%
Interest Expense00000000000000000000
Non-Operating Income00000000000000000000
Pretax Income-34.6M-20.6M-36.3M-42.6M-61.4M-37.8M-65.8M-55.1M-45.2M-39.6M-59.6M-65.9M-64.7M-68.1M-89.1M-65M-72.6M-68.4M-64.2M-52.9M
Pretax Margin %-14.76%-9.03%-18.66%-25.96%-40.61%-25.4%-48.17%-45.16%-37.95%-34.29%-52.05%-63%-67.96%-77.04%-120.41%-130%-163.88%-166.83%-179.83%-187.59%
Income Tax1.2M1.1M1.2M1.3M1M-7.8M1.9M2.1M2.1M2.8M1.9M1.3M1.1M-4.4M2.3M2.9M2.2M1.9M2.2M2.7M
Effective Tax Rate %-3.47%-5.34%-3.31%-3.05%-1.63%20.63%-2.89%-3.81%-4.65%-7.07%-3.19%-1.97%-1.7%6.46%-2.58%-4.46%-3.03%-2.78%-3.43%-5.1%
Net Income-35.8M-21.7M-37.5M-43.9M-62.4M-30M-67.7M-57.2M-47.3M-42.4M-61.5M-67.2M-65.8M-63.7M-91.4M-67.9M-74.8M-70.3M-66.4M-55.6M
Net Margin %-15.27%-9.51%-19.28%-26.75%-41.27%-20.16%-49.56%-46.89%-39.71%-36.71%-53.71%-64.24%-69.12%-72.06%-123.51%-135.8%-168.85%-171.46%-185.99%-197.16%
Net Income Growth %42.63%27.67%44.61%23.25%-31.92%29.25%-10.08%14.88%28.12%33.44%32.71%1.03%12.03%9.39%-37.65%-22.12%-52.65%-107.37%-114.89%-164.76%
EPS (Diluted)-0.47-0.33-0.51-0.60-0.86-0.42-0.95-0.81-0.67-0.61-0.88-0.97-0.95-0.92-1.37-1.10-1.21-1.14-1.08-0.90
EPS Growth %45.35%21.43%46.32%25.93%-28.36%31.15%-7.95%16.49%29.47%33.7%35.77%11.82%21.49%19.3%-26.85%-22.22%-49.38%-90.48%-89.47%-136.84%
EPS (Basic)-0.47-0.33-0.51-0.60-0.86-0.42-0.95-0.81-0.67-0.61-0.88-0.97-0.95-0.92-1.37-1.10-1.21-1.14-1.08-0.90
Diluted Shares Outstanding76.31M71.82M74.19M73.43M72.92M71.02M71.14M70.72M70.28M70M69.75M69.53M69.33M64.92M66.88M61.82M61.7M61.7M61.58M61.44M